Overview

A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of glycopyrrolate compared to vehicle for the treatment of axillary hyperhidrosis.
Phase:
Phase 2
Details
Lead Sponsor:
Dermira, Inc.
Journey Medical Corporation
Treatments:
Glycopyrrolate